-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/cesarean-birth-2010_research-protocol.pdf
January 01, 2010 - o Birthing center location
o Technology use
o Ambulation
o Positioning
o Feeding
o 2nd-stage … o Birthing center location
o Technology use
o Ambulation
o Positioning
o Feeding
o 2nd-stage … We will develop a simple categorization scheme for coding the reasons that articles, at the
stage of
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/glaucoma-screening_research-protocol.pdf
November 16, 2010 - 3) there is an accurate test that detects the condition
during the asymptomatic or early clinical stage … ; 4) treatment at this asymptomatic or early stage
improves important health outcomes more than treatment … Subgroup analysis
If there are sufficient data, we will conduct subgroup analyses by stage or severity
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/autism_research-protocol.pdf
December 09, 2009 - of effect modifiers (e.g., simultaneous therapies/synergistic effects, participants’
developmental stage … Leads will design the
data collection forms and test them on multiple articles before initiating each stage … We will develop a simple categorization scheme for coding the reasons that articles, at the
stage of
-
effectivehealthcare.ahrq.gov/sites/default/files/therapies-for-autism-spectrum-disorder-2-9-2010.pdf
January 01, 2010 - of effect modifiers (e.g., simultaneous therapies/synergistic effects, participants’
developmental stage … Leads will design the
data collection forms and test them on multiple articles before initiating each stage … We will develop a simple categorization scheme for coding the reasons that articles, at the
stage of
-
effectivehealthcare.ahrq.gov/sites/default/files/blumenthal-presentation.pdf
May 29, 2025 - studying with
my colleagues decision
making around
end-‐of-‐life decisions,
where
end-‐stage … Going
back to the study that we did
with
the end-‐stage heart failure patients who were being
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/methods-future-value-of-information_research.pdf
June 01, 2011 - pENG =
$0.7M, SS =
346/arm*
B: pENG =
$0.4M, SS =
284/arm*,§
C: pENG =
$1,4M, SS =
155/arm (stage … 1), 124/arm
(stage 2)*
D: Global pENG
= 0, global SS =
0/arm (U.S.), 0,
0/arm (U.K.),
$0.9M, … )
E: pENG =
38.2M, SS =
489/arm*,†
A: pENG = $0,
SS = 0/arm
C: pENG =
$1.6M, SS =
66/arm (stage … 1), 163/arm
(stage 2)*
- - pEVPI: $23M* - pEVPI: €365k
(NL) / €10.2M
(EU)*
- pENBS = NA
(NL … Determining optimal
sample sizes for multi-stage randomized
clinical trials using value of information
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/pressure-ulcer-prevention_research-protocol.pdf
January 10, 2012 - , further examining effects of setting* and patient
characteristics
†
on incidence
o Severity/stage … pressure ulcers, further examining effects of setting* and patient
characteristics
†
on severity/stage … examining effects of risk level, setting*, and
patient characteristics
†
on incidence
o Severity/stage … ulcers, further examining effects of risk level, setting*, and
patient characteristics
†
on severity/stage
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/infantile-hemangioma_clinician.pdf
June 01, 2016 - ��Studies differed widely in terms of IH stage and lesion
location. … It is unclear if findings are applicable to children
of specific ages, with a particular stage of IH
-
effectivehealthcare.ahrq.gov/sites/default/files/developmental-delays-horizon-scan-high-impact-1506.pdf
December 01, 2015 - previous High Impact report, have demonstrated promising efficacy and are under
investigation in late-stage
-
effectivehealthcare.ahrq.gov/sites/default/files/developmental-delays-horizon-scan-high-impact-1512.pdf
December 01, 2015 - This new formulation was added to the system in 2014 as a therapy in
late-stage development for treating
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/machine-learning-tools-appendix-d.xlsx
January 01, 2024 - Data extraction tools
PMID Authors Title PubYear Tool_name Environment Access Model_name Model_type Training ESP_Task Specific_ESP_task Prompts_reported Inputs Outputs Notes Reference_standard Validation N_runs Reports_tested Outcome_description Summary_measure Kappa Kappa_dispersion Correctness Correctness_low Correc…
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/TND-555-09-03-2013.pdf
January 01, 2013 - populations, interventions, comparators, and
outcomes, will be further developed in the refinement stage
-
effectivehealthcare.ahrq.gov/sites/default/files/communicating_risk_international_king.ppt
January 01, 2005 - Decisions and Communications Science Center
Oregon Health & Science University
Overview
Set the Stage—International
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/gastric-cancers-supplementary-app-d.xlsx
January 01, 2023 - trial and about halfway they increased the dose of a med (doxifluridine) - also noticed more lower stage … trial and about halfway they increased the dose of a med (doxifluridine) - also noticed more lower stage
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/colorectal-cancer-screening_research-protocol.pdf
May 18, 2011 - CRC screening improves health outcomes by detecting early
stage cancer, which has a better prognosis … included
studies, including those that are questionable based on limited reporting at the abstract
stage … addition, we will code the reasons for exclusion of articles considered at the full-
article review stage
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/psoriasis-chronic_research-protocol.pdf
January 10, 2012 - † Plaque psoriasis development stage is described by: Phase (number of studies): status (if applicable … epidermoidcarcinomas of the head and neck, advanced mycosis fungoides, lung cancer, and
advanced-stage … Marketed By
(Manufacturer)
FDA Indications Status in United States/Plaque psoriasis
development stage … chronic kidney disease on dialysis;
treatment of secondary hyperparathyroidism in patients
with stage … † Plaque psoriasis development stage is described by: Phase (number of studies): status (if applicable
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/transitions-care-pediatric-to-adult-services-disposition-comments.pdf
May 31, 2022 - However, we
note that the majority of included studies are in Stage I of the
National Institutes of … Health Stage Model. … Stage I
encompasses the generation of new behavioral interventions
as well as feasibility and pilot … IV), or implementation and dissemination of
interventions in community settings (Stage V). … 1
In the NIH stages model, Stage I encompasses the
generation of new behavioral interventions as
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/breast-cancer-imaging_technical-brief.pdf
October 01, 2014 - Indication for imaging Imaging for treatment evaluation Diagnostic imaging
Imaging used to assess stage … II-IV
BC; life
expectancy
>3 months
5
stage
IV
54
(36-80)
FLT-PET/CT FLT-PET/CT 1
week … Axillary lymph node dissection in early-
stage invasive breast cancer: is it still standard today? … FDG PET evaluation of early
axillary lymph node response to neoadjuvant chemotherapy in stage II and … Inhibition of HER2/estrogen receptor cross-talk, probable relation
to prolonged remission of stage IV
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/recombinant-factor-viia_disposition-comments.pdf
June 01, 2010 - rFVIIa use may occur
prophylactically, as a treatment for a specific bleeding problem,
and in end-stage … In addition, we also discuss the types of use
(prophylactic, treatment, and end-stage) that are pertinent … as an end-stage measure. … The inherent difficulties in studying end-stage and
emergent use of rFVIIa contribute to this mismatch … We also discuss the type of use
(prophylactic, treatment, and end-stage) within the context of
our
-
effectivehealthcare.ahrq.gov/sites/default/files/diabetes-horizon-scan-high-impact-1412.pdf
January 01, 2015 - ITCA 650 pump system compared with twice-daily exenatide
injections (Ex-BID) was evaluated in a two-stage … Stage II (n=131) randomly reassigned
patients to receive 20, 40, 60, or 80 mcg/day of ITCA 650 for … Stage I mean change in HbA1c (from a mean baseline of
7.9% to 8.0%) for the 20 and 40 mcg/day ITCA … Stage II patients had significant (p<0.05) reductions in HbA1c
(∼1.4% from baseline) with 60 and 80 … Medtronic to seek new CMS code for
early-stage artificial pancreas. [internet].